A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is $185.5, with a 24-hour trading volume of $313.39M. The asset's market cap is $287.67B, after moving -1.40% in the last day.
Tokenized AstraZeneca PLC is trading at $103.72, with a tokenized market cap of $14.2M and a 24-hour trading volume of $743.13K. The tokenized asset has moved -3.10% in the past 24 hours.